Call for Abstract
Scientific Program
3rd World Congress on Cancer Science & Therapy, will be organized around the theme “Innovations and Novel Therapeutic Strategies in Cancer Science”
Cancer Science-2013 is comprised of 10 tracks and 61 sessions designed to offer comprehensive sessions that address current issues in Cancer Science-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Cancer: Gene expression and protein profiling; Surgery and laparoscopy
- Track 1-2Radiotherapy and chemotherapy
- Track 1-3Hormone replacement therapy
- Track 1-4Molecular-targeted therapies
- Track 1-5Clinical medicine and targeting anti cancer drugs
- Track 1-6Therapeutic targets in cancer
- Track 1-7Clinical research in cancer immunology
- Track 1-8Anticancer gene therapy and stem cells therapy
- Track 1-9Cancer metabolism
- Track 1-10Molecular cancer biology
- Track 2-1Cancer stem cells and metastatic growth
- Track 2-2Cell signaling and membrane proteins: Inflammation and inflammatory factors in cancer development
- Track 2-3Metastatic cell growth and adhesion: Apoptosis and cell division
- Track 2-4Biomarkers in cancer therapy and molecular diagnostics
- Track 2-5DNA methylation and mutation based biomarkers, prognostic biomarkers
- Track 2-6Biomarkers based on cancer types
- Track 3-1Organ cancers: Breast, lung, brain, skin, and sarcomas
- Track 3-2Liver, prostate, kidney, ovarian and cervical cancer
- Track 3-3Blood, lung and leukemia cancer
- Track 3-4Bone and thyroid cancer
- Track 3-5Gastrointestinal and colorectal cancer
- Track 4-1Metabolism of carcinogens
- Track 4-2Biological and external factors for carcinogenesis
- Track 4-3Cancer Research: Clinical and experimental oncology
- Track 4-4Cancer cell lines: Genomics and proteomics
- Track 5-1Biomarkers in cancer detection
- Track 5-2Diet and physical exercise
- Track 5-3Chemoprevention
- Track 5-4Environmental factors
- Track 5-5Chemotherapy of cancers
- Track 6-1New cancer biomarkers as drug targets
- Track 6-2Anticancer drugs targeting protein kinase inhibitors
- Track 6-3Anticancer drugs targeting Tumor Necrosis Factor (TNF) and chemokine receptors
- Track 6-4Antibodies for cancer therapy
- Track 6-5Anticancer drugs targeting signalling pathways and regulators
- Track 6-6Anticancer drugs targeting GPCR, nuclear receptor inhibitors and hormonal therapies
- Track 6-7Apoptotic inducers, targeting apoptosis signaling pathways and their mediators
- Track 7-1Protein chips, tissue chips, lab-on-chip and microarray
- Track 7-2Proteomics, genomics and other Omics in cancer research
- Track 7-3pet, cancer digital imaging and image-guided technologies
- Track 7-4Anticancer drug resistance and new molecule searching
- Track 7-5Bioinformatics, drug design and computer aided anticancer drug discovery
- Track 8-1Tumor virology
- Track 8-2Tumor immunology and immunotherapy
- Track 8-3Tumor microenvironment and research
- Track 8-4Tumor varieties: Benign, pre-malignant, and malignant
- Track 8-5Tumor progression, invasion and metastasis
- Track 9-1Molecular cancer therapeutics
- Track 9-2Clinical and potential applications of metabolomics in oncology
- Track 9-3Metabolomics in novel biomarker discovery
- Track 9-4Revisiting tumor metabolism
- Track 9-5Telomerase: A target for cancer therapeutics
- Track 9-6Analytical and bio-analytical techniques in metabolomics
- Track 9-7Transcriptomics
- Track 9-8Toxicology and drug metabolism
- Track 10-1Current Trends and Innovations in Metabolomics
- Track 10-2Computational biology, current synthetic biology and systems biology
- Track 10-3Computational genomics
- Track 10-4Metabolomics syndrome
- Track 10-5Recent approaches in proteomics and genomics
- Track 10-6Glycomics and lipidomics